Patent · US Active

Cas9 crystals and methods of use thereof

US9963689B2 · kind B2 · utility

17Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 29, 2014
Grant dateMay 8, 2018
Priority date
Expiry dateDec 29, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2299/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides atomic structures of Cas9 with and without polynucleotides bound thereto. Also provided is a computer-readable medium comprising atomic coordinates for Cas9 polypeptides in both an unbound configuration and a configuration wherein the Cas9 polypeptide is bound to one or more polynucleotides. The present disclosure provides crystals comprising Cas9 polypeptides; and compositions comprising the crystals. The present disclosure provides methods for the engineering of Cas9 polypeptides wherein Cas9 activity has been altered, ablated, or preserved and amended with additional activities.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.